Human Influenza B victoria virus B/France/IDF-RELAB-IPP14156/2024, D197N mutation
virus

Human Influenza B victoria virus B/France/IDF-RELAB-IPP14156/2024, D197N mutation

ANTIVIRAL RESISTANT STRAIN

EVAg
Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
017V-06226
Human Influenza B victoria virus B/France/IDF-RELAB-IPP14156/2024, D197N mutation, isolate of 2024-2024 epidemic season
Product Risk Group: 
RG2
ICTV Taxonomy: 
Riboviria / Orthornavirae / Negarnaviricota / Polyploviricotina / Insthoviricetes / Articulavirales / Orthomyxoviridae / Betainfluenzavirus / Influenza B virus
Virus name: 
Influenza B virus
Strain: 
B/France/IDF-RELAB-IPP14156/2024 (B victoria)
Genotype: 
Clade V1A.3a.2
Serotype: 
B/Austria/1359417/2021-like

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1 nunc tube, freezed, 500µL

In stock

500,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
Antiviral resistant strain
GMO: 
No
Biosafety restrictions: 
BSL2
Virus host type: 
Human virus
Infectivity Test: 
plate titer and hemagglutination test (HA 64)
Viral titer: 
virus titer 3.8.10^10 PFU/mL
Production cell line: 
MDCK
Virus Cultivability: 
Cultivable virus
Passage: 
C2
Shipping conditions: 
Dry ice
IATA Classification: 
Category B, UN3373

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Friday, 6 December, 2024
Country of collection: 
France
Suspected epidemiological origin : 
Ile de France
France
Isolation host: 
Human
Isolation technique: 
3 days incubation in MDCK cell culture
Isolation conditions: 
35°C and 5% CO2